US Stock MarketDetailed Quotes

AMPH Amphastar Pharmaceuticals

Watchlist

42.850
-1.210-2.75%

Close Aug 9 16:00 ET

2.10BMarket Cap13.60P/E (TTM)

Amphastar Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

25.83%69.11M

36.92%55.29M

105.76%183.5M

56.73%23.86M

215.75%64.33M

1,851.08%54.92M

-20.45%40.38M

-8.99%89.18M

-62.35%15.23M

693.11%20.38M

Net income from continuing operations

45.26%37.95M

65.86%43.18M

50.51%137.55M

6.65%36.17M

210.08%49.22M

50.61%26.12M

7.34%26.03M

44.37%91.39M

71.62%33.91M

-48.73%15.87M

Operating gains losses

-93.56%164K

-514.66%-4.07M

986.79%7.79M

933.94%6.86M

-295.13%-2.6M

-12.54%2.55M

142.53%982K

93.25%-878K

-48.11%-822K

94.74%-657K

Depreciation and amortization

101.47%14.15M

88.79%13.96M

47.75%41.78M

88.22%13.79M

85.27%13.57M

2.81%7.02M

8.84%7.4M

6.57%28.28M

15.70%7.33M

12.52%7.33M

Deferred tax

----

12.79%-13.74M

----

-474.22%-15.75M

----

Other non cash items

-23.64%2.44M

3,506.78%2.13M

2,346.14%11.4M

9,610.00%2.91M

2,046.31%5.24M

--3.19M

--59K

112.79%466K

--30K

--244K

Change In working capital

1.85%8.64M

-3,569.19%-7.27M

24.76%-24.21M

-94.17%-26.75M

14.40%-5.74M

129.54%8.48M

-101.16%-198K

-1,549.26%-32.18M

-216.77%-13.77M

78.70%-6.71M

-Change in receivables

428.82%6.68M

-96.69%-23.2M

-157.46%-26.09M

135.39%4.09M

-645.46%-19.64M

116.24%1.26M

-310.72%-11.8M

32.10%-10.13M

-1,430.46%-11.56M

129.56%3.6M

-Change in inventory

-578.74%-7.03M

-3,829.48%-10M

85.32%-1.72M

309.27%4.81M

-4.91%-5.77M

78.14%-1.04M

109.97%268K

-1,033.70%-11.75M

-83.26%1.18M

-33.85%-5.5M

-Change in prepaid assets

-16.89%433K

-187.67%-192K

-47.14%-2.73M

11.36%-2.83M

-172.65%-635K

154.73%521K

-84.58%219K

-163.34%-1.85M

-282.32%-3.2M

300.46%874K

-Change in payables and accrued expense

341.46%13.73M

318.53%23.08M

1,898.51%13.24M

75.06%-3.39M

2,803.38%8M

-15.97%3.11M

-41.60%5.51M

-120.25%-736K

-1,162.27%-13.58M

97.99%-296K

-Change in other current liabilities

-7.09%-951K

-9.86%-947K

-13.79%-3.59M

-8.34%-922K

-9.82%-917K

-14.88%-888K

-24.03%-862K

1.38%-3.15M

-27.20%-851K

-22.79%-835K

-Change in other working capital

-176.72%-4.23M

-38.19%3.99M

27.14%-3.32M

-300.25%-28.5M

390.25%13.22M

130.33%5.51M

64.52%6.46M

-154.56%-4.56M

158.00%14.23M

-841.69%-4.55M

Cash from discontinued investing activities

Operating cash flow

25.83%69.11M

36.92%55.29M

105.76%183.5M

56.73%23.86M

215.75%64.33M

1,851.08%54.92M

-20.45%40.38M

-8.99%89.18M

-62.35%15.23M

693.11%20.38M

Investing cash flow

Cash flow from continuing investing activities

86.26%-69.9M

340.60%15.24M

-1,880.40%-649.12M

-44,899.56%-103.05M

-104.17%-31.15M

-6,117.38%-508.58M

30.48%-6.33M

-14.32%-32.78M

98.08%-229K

-304.83%-15.26M

Net PPE purchase and sale

33.24%-6.04M

7.22%-8.79M

-61.63%-38.17M

-49.64%-9.44M

-81.27%-10.19M

-63.40%-9.05M

-54.37%-9.48M

14.00%-23.61M

8.26%-6.31M

22.11%-5.62M

Net business purchase and sale

----

---506.41M

--0

---5.58M

----

--0

Net investment purchase and sale

2,888.67%66.74M

664.31%24.03M

-1,259.52%-105.93M

-1,357.46%-91.93M

-104.19%-19.38M

178.88%2.23M

213.01%3.14M

-658.17%-7.79M

304.90%7.31M

-354.49%-9.49M

Net other investing changes

----

201.31%1.39M

-36.10%-1.67M

2,855.86%4M

----

47.47%-1.37M

18.44%-1.23M

48.03%-145K

Cash from discontinued investing activities

Investing cash flow

86.26%-69.9M

340.60%15.24M

-1,880.40%-649.12M

-44,899.56%-103.05M

-104.17%-31.15M

-6,117.38%-508.58M

30.48%-6.33M

-14.32%-32.78M

98.08%-229K

-304.83%-15.26M

Financing cash flow

Cash flow from continuing financing activities

-102.50%-10.72M

-0.23%-13.58M

1,817.51%454.09M

-191.31%-47.08M

721.72%86.61M

43,169.52%428.11M

-391.48%-13.55M

28.58%-26.44M

-85.86%-16.16M

15.53%-13.93M

Net issuance payments of debt

-101.86%-8.03M

511.57%3.98M

29,653.17%526.34M

-39,081.25%-50.15M

27,863.60%144.93M

73,040.30%432.54M

-79.93%-968K

-105.55%-1.78M

79.12%-128K

-101.28%-522K

Net common stock issuance

-6,539.06%-8.5M

--0

-45.69%-58.14M

--0

-244.98%-50M

97.91%-128K

-552.16%-8.02M

-38.22%-39.91M

-34.48%-18.07M

-137.88%-14.49M

Proceeds from stock option exercised by employees

-40.98%5.82M

-279.21%-17.31M

-29.91%10.97M

74.68%3.56M

51.86%2.13M

70.38%9.85M

-170.92%-4.57M

-1.68%15.66M

-64.00%2.04M

-63.82%1.4M

Net other financing activities

--1K

---252K

-6,061.92%-25.08M

-16,266.67%-491K

-3,213.65%-10.44M

----

99.28%-407K

99.03%-3K

99.43%-315K

Cash from discontinued financing activities

Financing cash flow

-102.50%-10.72M

-0.23%-13.58M

1,817.51%454.09M

-191.32%-47.08M

721.73%86.61M

43,169.52%428.11M

-391.48%-13.55M

28.58%-26.44M

-85.86%-16.16M

15.53%-13.93M

Net cash flow

Beginning cash position

13.87%201.38M

-7.55%144.53M

23.50%156.33M

72.11%271.04M

-9.08%151.28M

2.31%176.85M

23.50%156.33M

33.95%126.59M

47.39%157.48M

33.55%166.39M

Current changes in cash

54.95%-11.51M

177.79%56.95M

-138.44%-11.52M

-10,738.45%-126.27M

1,459.14%119.8M

-301.76%-25.55M

-55.72%20.5M

-7.24%29.97M

-105.89%-1.17M

50.18%-8.81M

Effect of exchange rate changes

13.64%-19K

-706.25%-97K

-28.18%-282K

-1,352.63%-238K

61.62%-38K

80.18%-22K

155.17%16K

1.35%-220K

139.58%19K

-83.33%-99K

End cash Position

25.50%189.85M

13.87%201.38M

-7.55%144.53M

72.11%271.04M

-9.08%151.28M

2.31%176.85M

23.50%156.33M

47.39%157.48M

Free cash flow

37.49%63.07M

50.45%46.5M

123.09%145.34M

61.75%14.42M

267.01%54.14M

1,557.55%45.87M

-30.75%30.91M

-7.64%65.15M

-73.44%8.92M

417.25%14.75M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	25.83%69.11M	36.92%55.29M	105.76%183.5M	56.73%23.86M	215.75%64.33M	1,851.08%54.92M	-20.45%40.38M	-8.99%89.18M	-62.35%15.23M	693.11%20.38M
Net income from continuing operations	45.26%37.95M	65.86%43.18M	50.51%137.55M	6.65%36.17M	210.08%49.22M	50.61%26.12M	7.34%26.03M	44.37%91.39M	71.62%33.91M	-48.73%15.87M
Operating gains losses	-93.56%164K	-514.66%-4.07M	986.79%7.79M	933.94%6.86M	-295.13%-2.6M	-12.54%2.55M	142.53%982K	93.25%-878K	-48.11%-822K	94.74%-657K
Depreciation and amortization	101.47%14.15M	88.79%13.96M	47.75%41.78M	88.22%13.79M	85.27%13.57M	2.81%7.02M	8.84%7.4M	6.57%28.28M	15.70%7.33M	12.52%7.33M
Deferred tax	----	----	12.79%-13.74M	----	----	----	----	-474.22%-15.75M	----	----
Other non cash items	-23.64%2.44M	3,506.78%2.13M	2,346.14%11.4M	9,610.00%2.91M	2,046.31%5.24M	--3.19M	--59K	112.79%466K	--30K	--244K
Change In working capital	1.85%8.64M	-3,569.19%-7.27M	24.76%-24.21M	-94.17%-26.75M	14.40%-5.74M	129.54%8.48M	-101.16%-198K	-1,549.26%-32.18M	-216.77%-13.77M	78.70%-6.71M
-Change in receivables	428.82%6.68M	-96.69%-23.2M	-157.46%-26.09M	135.39%4.09M	-645.46%-19.64M	116.24%1.26M	-310.72%-11.8M	32.10%-10.13M	-1,430.46%-11.56M	129.56%3.6M
-Change in inventory	-578.74%-7.03M	-3,829.48%-10M	85.32%-1.72M	309.27%4.81M	-4.91%-5.77M	78.14%-1.04M	109.97%268K	-1,033.70%-11.75M	-83.26%1.18M	-33.85%-5.5M
-Change in prepaid assets	-16.89%433K	-187.67%-192K	-47.14%-2.73M	11.36%-2.83M	-172.65%-635K	154.73%521K	-84.58%219K	-163.34%-1.85M	-282.32%-3.2M	300.46%874K
-Change in payables and accrued expense	341.46%13.73M	318.53%23.08M	1,898.51%13.24M	75.06%-3.39M	2,803.38%8M	-15.97%3.11M	-41.60%5.51M	-120.25%-736K	-1,162.27%-13.58M	97.99%-296K
-Change in other current liabilities	-7.09%-951K	-9.86%-947K	-13.79%-3.59M	-8.34%-922K	-9.82%-917K	-14.88%-888K	-24.03%-862K	1.38%-3.15M	-27.20%-851K	-22.79%-835K
-Change in other working capital	-176.72%-4.23M	-38.19%3.99M	27.14%-3.32M	-300.25%-28.5M	390.25%13.22M	130.33%5.51M	64.52%6.46M	-154.56%-4.56M	158.00%14.23M	-841.69%-4.55M
Cash from discontinued investing activities
Operating cash flow	25.83%69.11M	36.92%55.29M	105.76%183.5M	56.73%23.86M	215.75%64.33M	1,851.08%54.92M	-20.45%40.38M	-8.99%89.18M	-62.35%15.23M	693.11%20.38M
Investing cash flow
Cash flow from continuing investing activities	86.26%-69.9M	340.60%15.24M	-1,880.40%-649.12M	-44,899.56%-103.05M	-104.17%-31.15M	-6,117.38%-508.58M	30.48%-6.33M	-14.32%-32.78M	98.08%-229K	-304.83%-15.26M
Net PPE purchase and sale	33.24%-6.04M	7.22%-8.79M	-61.63%-38.17M	-49.64%-9.44M	-81.27%-10.19M	-63.40%-9.05M	-54.37%-9.48M	14.00%-23.61M	8.26%-6.31M	22.11%-5.62M
Net business purchase and sale	----	----	---506.41M	--0	---5.58M	----	----	--0	--0	--0
Net investment purchase and sale	2,888.67%66.74M	664.31%24.03M	-1,259.52%-105.93M	-1,357.46%-91.93M	-104.19%-19.38M	178.88%2.23M	213.01%3.14M	-658.17%-7.79M	304.90%7.31M	-354.49%-9.49M
Net other investing changes	----	----	201.31%1.39M	-36.10%-1.67M	2,855.86%4M	----	----	47.47%-1.37M	18.44%-1.23M	48.03%-145K
Cash from discontinued investing activities
Investing cash flow	86.26%-69.9M	340.60%15.24M	-1,880.40%-649.12M	-44,899.56%-103.05M	-104.17%-31.15M	-6,117.38%-508.58M	30.48%-6.33M	-14.32%-32.78M	98.08%-229K	-304.83%-15.26M
Financing cash flow
Cash flow from continuing financing activities	-102.50%-10.72M	-0.23%-13.58M	1,817.51%454.09M	-191.31%-47.08M	721.72%86.61M	43,169.52%428.11M	-391.48%-13.55M	28.58%-26.44M	-85.86%-16.16M	15.53%-13.93M
Net issuance payments of debt	-101.86%-8.03M	511.57%3.98M	29,653.17%526.34M	-39,081.25%-50.15M	27,863.60%144.93M	73,040.30%432.54M	-79.93%-968K	-105.55%-1.78M	79.12%-128K	-101.28%-522K
Net common stock issuance	-6,539.06%-8.5M	--0	-45.69%-58.14M	--0	-244.98%-50M	97.91%-128K	-552.16%-8.02M	-38.22%-39.91M	-34.48%-18.07M	-137.88%-14.49M
Proceeds from stock option exercised by employees	-40.98%5.82M	-279.21%-17.31M	-29.91%10.97M	74.68%3.56M	51.86%2.13M	70.38%9.85M	-170.92%-4.57M	-1.68%15.66M	-64.00%2.04M	-63.82%1.4M
Net other financing activities	--1K	---252K	-6,061.92%-25.08M	-16,266.67%-491K	-3,213.65%-10.44M	----	----	99.28%-407K	99.03%-3K	99.43%-315K
Cash from discontinued financing activities
Financing cash flow	-102.50%-10.72M	-0.23%-13.58M	1,817.51%454.09M	-191.32%-47.08M	721.73%86.61M	43,169.52%428.11M	-391.48%-13.55M	28.58%-26.44M	-85.86%-16.16M	15.53%-13.93M
Net cash flow
Beginning cash position	13.87%201.38M	-7.55%144.53M	23.50%156.33M	72.11%271.04M	-9.08%151.28M	2.31%176.85M	23.50%156.33M	33.95%126.59M	47.39%157.48M	33.55%166.39M
Current changes in cash	54.95%-11.51M	177.79%56.95M	-138.44%-11.52M	-10,738.45%-126.27M	1,459.14%119.8M	-301.76%-25.55M	-55.72%20.5M	-7.24%29.97M	-105.89%-1.17M	50.18%-8.81M
Effect of exchange rate changes	13.64%-19K	-706.25%-97K	-28.18%-282K	-1,352.63%-238K	61.62%-38K	80.18%-22K	155.17%16K	1.35%-220K	139.58%19K	-83.33%-99K
End cash Position	25.50%189.85M	13.87%201.38M	-7.55%144.53M	-7.55%144.53M	72.11%271.04M	-9.08%151.28M	2.31%176.85M	23.50%156.33M	23.50%156.33M	47.39%157.48M
Free cash flow	37.49%63.07M	50.45%46.5M	123.09%145.34M	61.75%14.42M	267.01%54.14M	1,557.55%45.87M	-30.75%30.91M	-7.64%65.15M	-73.44%8.92M	417.25%14.75M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall